Cancer research and development landscape: overview of 1999-2022 period
Overview
Despite significant progress
in therapeutic development,
cancer is still associated with
a substantial global disease
burden, which is projected to
increase significantly in the
coming decades, particularly in
low- and lower middle-income
countries. Cancer clinical
trials play a critical role not
only at the individual level by
allowing timely access to the
most innovative preventive and
treatment strategies but also at
the population level, fostering
advancements that contribute
to a broader understanding of
cancer and its management,
and improving collective health
care practices. This report
offers a landscape analysis
on global cancer clinical
trials in 2023 using the World
Health Organization (WHO)
International Clinical Trials
Registry Platform (ICTRP) and
Global Observatory on Health
Research and Development
(R&D).
